nomifensine has been researched along with Vomiting in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohn, JB | 1 |
| Varga, L | 1 |
| Lyford, A | 1 |
1 trial available for nomifensine and Vomiting
| Article | Year |
|---|---|
A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Topics: Aged; Akathisia, Drug-Induced; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Doubl | 1984 |